[Clinical studies on renal cell carcinoma]

Area of Science:

• Oncology
• Urology
• Medical Statistics

Context:

• Renal cell carcinoma (RCC) is a significant health concern, necessitating accurate prognostic indicators for effective patient management.
• Previous studies have identified various factors influencing RCC outcomes, but a refined prognostic model is crucial for clinical application.
• This research focuses on patients treated at Osaka Police Hospital, providing specific data from a defined cohort.

Purpose:

• To identify independent prognostic factors for cause-specific survival in patients with renal cell carcinoma.
• To develop a risk stratification model based on identified prognostic factors for improved patient management.
• To evaluate the survival rates associated with different risk groups derived from the prognostic model.

Summary:

• A cohort of 193 renal cell carcinoma patients was analyzed using Kaplan-Meier and Cox proportional hazards models.
• Univariate analysis revealed numerous prognostic factors, while multivariate analysis pinpointed high age (≥60 years), positive C-reactive protein (CRP), and T4 stage as independent poor prognosticators.
• A risk stratification system was developed, classifying patients into 0, 1, 2, or 3 risk groups based on these factors, demonstrating significantly different survival rates.

Impact:

• The study establishes a robust prognostic model for renal cell carcinoma, enabling better prediction of patient outcomes.
• The identified risk factors (high age, positive CRP, T4 stage) can guide clinical decision-making regarding follow-up intensity and the necessity of adjuvant therapy.
• This risk stratification has the potential to personalize treatment strategies, improving the management and survival of renal cell carcinoma patients.